Soliris 300 MG/30 ML vial 30ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMEG5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,547
Award facts
- Contract value 100% obligated
- $20,547.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $20,547.08 to DMS Pharmaceutical Group Inc. for SOLIRIS 300 mg/30 ml vials on January 28, 2026. This firm fixed-price delivery order is expected to be completed by February 19, 2026, and will be performed at the contractor's location in Park Ridge, Illinois. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has maintained an active federal contracting presence since 2001 and specializes in distributing a comprehensive range of pharmaceutical products and medical consumables to Department of Defense facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The prime contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military healthcare operations globally. The contractor's demonstrated performance across numerous prior delivery orders positions it as a critical pharmaceutical supplier for Department of Defense healthcare requirements. No subcontractors were identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FMEG5?
SPE2DR26FMEG5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FMEG5 worth?
The government has obligated $20,547 on SPE2DR26FMEG5.
Is contract SPE2DR26FMEG5 an order under another contract?
Yes. SPE2DR26FMEG5 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEG5 competed?
The extent of competition for SPE2DR26FMEG5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award